The FDA was explicit: affordability is not clinical need
Despite a negative trial of oral Ozempic in mild Alzheimers, the rationale for GLP-1 drugs in neurodegenerative disease remains strong
Women with a history of depression, anxiety, or mental health challenges should ensure their prescribing doctor is aware of this ongoing investigation and that their mental health is being monitored throughout treatment
#DidYouKnow #Chemotherapy #OncologyNursing #SafetyStandards To view or add a comment, sign in Our study on lisinopril showed that the branded drug was superior to two generic formulations in reducing systolic blood pressure in rats over two weeks, with no significant impact on liver and cardiac enzymes, and greater safety for kidney and heart function
Blood banks do not have a blanket policy against GLP-1 donors, but individual centers may have slightly different protocols
Code KILLA saves 15% on all King Killers apparel at checkout